Raymond James Financial »

Telomir Pharmaceuticals shares owned by Raymond James Financial

Quarter-by-quarter ownership of Telomir Pharmaceuticals (TELO) shares owned by Raymond James Financial from 13F filings

Historical chart of Raymond James Financial investment in Telomir Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Telomir Pharmaceuticals held by Raymond James Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Telomir Pharmaceuticals by Raymond James Financial

Quarter filed Position value Share count Share price at filing
2025-09-30 $105k 75k 1.39
2025-06-30 $2.2k 1.8k 1.25

More positions owned by Raymond James Financial

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Microsoft Corporation (MSFT)
Ishares Tr Core Us Aggbd Et (AGG)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Broadcom (AVGO)
Amazon (AMZN)
JPMorgan Chase & Co. (JPM)
Ishares Tr Core Msci Eafe (IEFA)
Alphabet Cap Stk Cl A (GOOGL)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Meta Platforms Cl A (META)
Ishares Tr Core S&p500 Etf (IVV)
Wal-Mart Stores (WMT)
Ishares Tr Core S&p Mcp Etf (IJH)

View all positions for Raymond James Financial

Top funds holding Telomir Pharmaceuticals

Vanguard Group
BlackRock
Millennium Management
Geode Capital Management
Raymond James Financial
UBS Group
State Street Corporation
Bank of New York Mellon
Suncoast Equity Management
Northern Trust
Morgan Stanley
Advisor Group Holdings
Resources Investment Advisors
Goldman Sachs Group
Praetorian Wealth Management

View all funds holding Telomir Pharmaceuticals